136 related articles for article (PubMed ID: 27501227)
1. HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice.
Holloway T; Moreno JL; González-Maeso J
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501227
[TBL] [Abstract][Full Text] [Related]
2. Role of mGlu2 in the 5-HT
Hideshima KS; Hojati A; Saunders JM; On DM; de la Fuente Revenga M; Shin JM; Sánchez-González A; Dunn CM; Pais AB; Pais AC; Miles MF; Wolstenholme JT; González-Maeso J
Psychopharmacology (Berl); 2018 Nov; 235(11):3149-3165. PubMed ID: 30209534
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.
Moreno JL; Holloway T; Rayannavar V; Sealfon SC; González-Maeso J
Neurosci Lett; 2013 Mar; 536():69-73. PubMed ID: 23333599
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic Glutamate
Benvenga MJ; Chaney SF; Baez M; Britton TC; Hornback WJ; Monn JA; Marek GJ
Front Pharmacol; 2018; 9():208. PubMed ID: 29599719
[TBL] [Abstract][Full Text] [Related]
7. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.
Moreno JL; Miranda-Azpiazu P; García-Bea A; Younkin J; Cui M; Kozlenkov A; Ben-Ezra A; Voloudakis G; Fakira AK; Baki L; Ge Y; Georgakopoulos A; Morón JA; Milligan G; López-Giménez JF; Robakis NK; Logothetis DE; Meana JJ; González-Maeso J
Sci Signal; 2016 Jan; 9(410):ra5. PubMed ID: 26758213
[TBL] [Abstract][Full Text] [Related]
8. Role of interaction of mGlu2 and 5-HT
Ibi D
Pharmacol Biochem Behav; 2022 Nov; 221():173474. PubMed ID: 36244526
[TBL] [Abstract][Full Text] [Related]
9. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
10. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
[TBL] [Abstract][Full Text] [Related]
11. Effects of the 5-HT
Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD
Neuropharmacology; 2020 May; 167():107933. PubMed ID: 31917152
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
[TBL] [Abstract][Full Text] [Related]
14. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.
Moreno JL; Muguruza C; Umali A; Mortillo S; Holloway T; Pilar-Cuéllar F; Mocci G; Seto J; Callado LF; Neve RL; Milligan G; Sealfon SC; López-Giménez JF; Meana JJ; Benson DL; González-Maeso J
J Biol Chem; 2012 Dec; 287(53):44301-19. PubMed ID: 23129762
[TBL] [Abstract][Full Text] [Related]
15. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
16. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
17. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
Benneyworth MA; Smith RL; Sanders-Bush E
Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214
[TBL] [Abstract][Full Text] [Related]
18. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
19. Differences across sexes on head-twitch behavior and 5-HT
Jaster AM; Younkin J; Cuddy T; de la Fuente Revenga M; Poklis JL; Dozmorov MG; González-Maeso J
Neurosci Lett; 2022 Sep; 788():136836. PubMed ID: 35963476
[TBL] [Abstract][Full Text] [Related]
20. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD
J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
